Passa al contenuto
Merck

SCP0134

Endothelin Antagonist PD 142893

Autenticati per visualizzare i prezzi organizzativi e contrattuali.

Scegli un formato

1 MG

190,00 €

5 MG

694,00 €

190,00 €


Per informazioni sulla disponibilità, contatta il Servizio Clienti.


Informazioni su questo articolo

Formula empirica (notazione di Hill):
C50H65N7O10
Peso molecolare:
924.09
NACRES:
NA.32
UNSPSC Code:
12352200

Vai a

Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutarti

assay

≥95% (HPLC)

form

lyophilized

composition

Peptide Content, ≥85%

storage condition

protect from light

storage temp.

−20°C

Confronta articoli simili

Visualizza il confronto per intero

Mostra le differenze

1 of 4

Questo articolo
SCP0137SCP0143SCP0136
assay

≥95% (HPLC)

assay

≥95% (HPLC)

assay

≥95% (HPLC)

assay

≥95% (HPLC)

form

lyophilized

form

lyophilized

form

lyophilized

form

lyophilized

storage condition

protect from light

storage condition

protect from light

storage condition

protect from light

storage condition

protect from light

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

composition

Peptide Content, ≥85%

composition

Peptide Content, ≥85%

composition

Peptide Content, ≥75%

composition

Peptide Content, ≥67%

Application

PD 142-893 is used as a nonselective endothelin ET(A)/ET(B) receptor antagonist.

Classe di stoccaggio

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

Non trovi la versione di tuo interesse?

Se hai bisogno di una versione specifica, puoi cercare il certificato tramite il numero di lotto.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Chumpon Wilasrusmee et al.
Surgery, 134(2), 384-389 (2003-08-30)
We have previously shown that endothelial injury by cyclosporin A (CyA) is associated with an increased endothelin-1 (ET-1) release. We now sought to determine, in an animal model of angiogenesis, if inhibiting the effect of ET-1 on endothelial cells (ECs)
Ashley M Stokes et al.
Canadian journal of veterinary research = Revue canadienne de recherche veterinaire, 70(3), 197-205 (2006-07-21)
The goals of this study were to determine the concentration-response (C-R) relationship of endothelin-1 (ET-1), compare 2 ET-receptor antagonists and determine the antagonist concentrations that block the vasomotor effects of ET-1, and compare the effectiveness of ET-1 and previously studied
Sebastien Faure et al.
Journal of vascular research, 43(1), 19-26 (2005-10-29)
The effect of angiotensin IV (AngIV) was studied in freshly isolated rat basilar arteries (BAs) perfused at a constant rate. AngIV had no effect on basal BA perfusion pressure, but induced a marked concentration-dependent contraction in vessels precontracted by a
Alexandra Madsen et al.
Journal of molecular and cellular cardiology, 154, 115-123 (2021-02-15)
The role of DNA methylation in cardiomyocyte physiology and cardiac disease remains a matter of controversy. We have recently provided evidence for an important role of DNMT3A in human cardiomyocyte cell homeostasis and metabolism, using engineered heart tissue (EHT) generated

Domande

Recensioni

Nessuna valutazione

Filtri attivi

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica